LDX.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Specialties

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2027	$21M	+58.5%	$-0.01	$-0.01–$-0.01	—	2
2028	$32M	+54.5%	$-0.01	$-0.01–$-0.01	—	2
2029	$40M	+27.1%	$-0.00	$-0.00–$-0.00	—	2

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 2 of the last 3 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-24	$-0.01	$-0.00	+99.0%
2023-08-29	$-0.07	$-0.02	+69.5%
2023-02-23	$-0.07	$-4.37	-6114.2%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
LDX.AXLumos Diagnostics Holdings Limited	$0.11	+10.00%	$104M	—
AHC.AXAustco Healthcare Limited	$0.27	+1.89%	$101M	—
AVH.AXAVITA Medical, Inc.	$2.80	+3.70%	$348M	—
EMV.AXEMVision Medical Devices Ltd	$1.73	+2.37%	$160M	—
MVF.AXMonash IVF Group Limited	$0.76

Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

lumosdiagnostics.com

Employees: 29
IPO / List date: Jul 5, 2021
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds LDX.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in LDX.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded LDX.AX yet.